Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis

A Spadaro, A Iagnocco, FM Perrotta, M Modesti… - …, 2011 - academic.oup.com
Objective. The aim of this study was to compare clinical examination with power Doppler US
(PDUS) in the detection of entheseal abnormalities in patients with AS. Methods. Thirty-six …

The sex influence on response to tumor necrosis factor-α inhibitors and remission in axial spondyloarthritis

E Lubrano, FM Perrotta, M Manara… - The Journal of …, 2018 - jrheum.org
Objective. The aim of this study was to evaluate the influence of sex on response to treatment
and disease remission in patients with axial spondyloarthritis (axSpA). Methods. In this …

Minimal disease activity and remission in psoriatic arthritis patients treated with anti-TNF-α drugs

FM Perrotta, A Marchesoni, E Lubrano - The Journal of Rheumatology, 2016 - jrheum.org
Objective. A state of remission is the target of therapy in chronic arthritis. The aim of the present
study was to assess the rate of minimal disease activity (MDA) and remission in patients …

Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: the ULISSE study

…, S Gasparini, C Perricone, FM Perrotta… - The Journal of …, 2019 - jrheum.org
Objective. The purpose of the ULISSE study was to evaluate the prevalence of clinical and
ultrasonographic (US) entheseal involvement in patients with psoriatic arthritis (PsA), psoriasis…

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study

…, R Ramonda, O Addimanda, FM Perrotta… - …, 2013 - academic.oup.com
Objective. The primary objective of this retrospective study was to investigate the possibility
of achieving partial remission (PR) in AS patients treated with anti-TNF-α antagonists, such …

Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors

E Lubrano, WJ Parsons, FM Perrotta - The Journal of Rheumatology, 2016 - jrheum.org
Objective. To assess the response to treatment, remission, and minimal disease activity (MDA)
in a group of patients with predominant axial psoriatic arthritis (axPsA). Predictors of …

To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis

FM Perrotta, R Lories, E Lubrano - RMD open, 2021 - rmdopen.bmj.com
In the last years, new researches focused on the role of biomechanical stress and microdamage
in the pathogenesis of inflammatory arthritis and, in particular, in axial spondyloarthritis (…

An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment

FM Perrotta, D Astorri, M Zappia, A Reginelli… - Rheumatology …, 2016 - Springer
The aim of this study was to evaluate the rate of power Doppler ultrasound (PDUS) abnormalities
at entheseal sites in patients with early psoriatic arthritis (PsA) naïve to traditional and …

[HTML][HTML] Clinical characteristics of potential “difficult-to-treat” patients with psoriatic arthritis: a retrospective analysis of a longitudinal cohort

FM Perrotta, S Scriffignano, F Ciccia… - Rheumatology and …, 2022 - Springer
Introduction The EULAR group recently published the definition of difficult-to-treat (D2T) patients
for rheumatoid arthritis. However, a similar definition is lacking for patients with psoriatic …

Secukinumab for ankylosing spondylitis and psoriatic arthritis

E Lubrano, FM Perrotta - Therapeutics and Clinical Risk …, 2016 - Taylor & Francis
The treatment of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) positively changed
since the introduction of anti-TNFα drugs. These treatments were shown to reduce the …